Docklands developer may face financial loss

Mirvac is facing a potential financial loss on its luxury Docklands residential development, Yarra Point.

Mirvac is facing a potential financial loss on its luxury Docklands residential development, Yarra Point.

The listed developer has booked only $150 million in sales in the $192.1 million project to date despite only 10 per cent of the units remaining unsold.

Construction of the 31-level, 201 apartment tower, which is Mirvac's sixth in the Yarra's Edge waterfront precinct, finished recently. The one, two and three-bedroom apartments and "Sky Residences" were put to market with prices of $510,000 to $2.4 million.

Mirvac declined to comment on whether it anticipated booking a loss after the remaining units were sold.

"Yarra Point sales remain on track to achieve our target returns and we are very pleased with the momentum that has continued over the past months," John Carfi, chief executive of Mirvac Residential, said.

"We have a number of Sky Residences still in stock that are steadily moving as well as four apartments throughout the tower that remain as display properties, allowing prospective purchasers to walk through and see first-hand the degree of space, quality and craftsmanship on offer at Yarra Point," he said.

The advertised prices of the apartments do not appear to have declined since the project was launched in 2010, according to Mirvac's published Property Compendiums.

The 14-hectare Yarra's Edge precinct is expected to deliver more than 2000 dwellings when completed. Other projects include the 39-level residential tower Array and 82 townhouses at River Homes.

Twitter: @chrisvedelago

InvestSMART FORUM: Come and meet the team

We're loading up the van and going on tour from April to June, with events on the NSW central & north coast, the QLD mid-north coast and in Perth, Adelaide, Melbourne, Sydney and Canberra. Come and meet the team and take home simple strategies that you can use to build an investment portfolio to weather any storm. Book your spot here.

Want access to our latest research and new buy ideas?

Start a free 15 day trial and gain access to our research, recommendations and market-beating model portfolios.

Sign up for free

Related Articles